E. Rubio

发表

Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality.

V. Cuervas-Mons, I. Millán, V. Turrión, 2003, Transplantation proceedings.

Midterm Results of Renal Transplantation From Controlled Cardiac Death Donors Are Similar to Those From Brain Death Donors.

J. Rubio, A. Huerta, P. López-Sánchez, 2016, Transplantation proceedings.

Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.

V. Cuervas-Mons, A. Herreros de Tejada, A. Gómez, 2003, Transplantation proceedings.

Cardiovascular morbidity and obesity in adult liver transplant recipients.

V. Cuervas-Mons, F. Mazuelos, V. Turrión, 2003, Transplantation proceedings.

Usefulness of mycophenolate mofetil in patients with chronic renal insufficiency after liver transplantation.

V. Cuervas-Mons, V. Sánchez-Turrión, A. Herreros de Tejada, 2003, Transplantation proceedings.

Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.

V. Cuervas-Mons, A. Herreros, J. Revilla, 2003, Transplantation proceedings.

Influence of infection by Aspergillus in arterial complications after liver transplantation: evolution and results in 670 transplants.

V. Cuervas-Mons, V. Turrión, F. Arrieta, 2011, Transplantation proceedings.

De novo malignancies and liver transplantation.

V. Cuervas-Mons, V. Turrión, J. Moreno, 2003, Transplantation proceedings.

Liver transplantationDe novo malignancies and liver transplantation

V. Cuervas-Mons, V. Sánchez-Turrión, J. Moreno, 2003 .

De novo malignancies in liver transplantation.

V. Cuervas-Mons, V. Sánchez-Turrión, J. Moreno, 2003, Transplantation proceedings.

Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantation.

V. Cuervas-Mons, J. M Moreno, E Rubio, 2003, Transplantation proceedings.